BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ruzic D, Djoković N, Srdić-rajić T, Echeverria C, Nikolic K, Santibanez JF. Targeting Histone Deacetylases: Opportunities for Cancer Treatment and Chemoprevention. Pharmaceutics 2022;14:209. [DOI: 10.3390/pharmaceutics14010209] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Ye J, Wu J, Liu B. Therapeutic strategies of dual-target small molecules to overcome drug resistance in cancer therapy. Biochim Biophys Acta Rev Cancer 2023;1878:188866. [PMID: 36842765 DOI: 10.1016/j.bbcan.2023.188866] [Reference Citation Analysis]
2 Tien Anh D, Hai Nam N, Kircher B, Baecker D. The Impact of Fluorination on the Design of Histone Deacetylase Inhibitors. Molecules 2023;28. [PMID: 36838960 DOI: 10.3390/molecules28041973] [Reference Citation Analysis]
3 Zhao A, Zhou H, Yang J, Li M, Niu T. Epigenetic regulation in hematopoiesis and its implications in the targeted therapy of hematologic malignancies. Signal Transduct Target Ther 2023;8:71. [PMID: 36797244 DOI: 10.1038/s41392-023-01342-6] [Reference Citation Analysis]
4 Abramson HN. Recent Advances in the Applications of Small Molecules in the Treatment of Multiple Myeloma. Int J Mol Sci 2023;24. [PMID: 36768967 DOI: 10.3390/ijms24032645] [Reference Citation Analysis]
5 Anestopoulos I, Kyriakou S, Tragkola V, Paraskevaidis I, Tzika E, Mitsiogianni M, Deligiorgi MV, Petrakis G, Trafalis DT, Botaitis S, Giatromanolaki A, Koukourakis MI, Franco R, Pappa A, Panayiotidis MI. Targeting the epigenome in malignant melanoma: Facts, challenges and therapeutic promises. Pharmacol Ther 2022;240:108301. [PMID: 36283453 DOI: 10.1016/j.pharmthera.2022.108301] [Reference Citation Analysis]
6 Chen G, Zhu X, Li J, Zhang Y, Wang X, Zhang R, Qin X, Chen X, Wang J, Liao W, Wu Z, Lu L, Wu W, Yu H, Ma L. Celastrol inhibits lung cancer growth by triggering histone acetylation and acting synergically with HDAC inhibitors. Pharmacological Research 2022;185:106487. [DOI: 10.1016/j.phrs.2022.106487] [Reference Citation Analysis]
7 Shen L, Li Y, Li N, Shen L, Li Z. Comprehensive analyses reveal the role of histone deacetylase genes in prognosis and immune response in low-grade glioma. PLoS One 2022;17:e0276120. [PMID: 36227941 DOI: 10.1371/journal.pone.0276120] [Reference Citation Analysis]
8 Nakagawa-saito Y, Saitoh S, Mitobe Y, Sugai A, Togashi K, Suzuki S, Kitanaka C, Okada M. HDAC Class I Inhibitor Domatinostat Preferentially Targets Glioma Stem Cells over Their Differentiated Progeny. IJMS 2022;23:8084. [DOI: 10.3390/ijms23158084] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 An T, Lu Y, Yan X, Hou J. Insights Into the Properties, Biological Functions, and Regulation of USP21. Front Pharmacol 2022;13:944089. [DOI: 10.3389/fphar.2022.944089] [Reference Citation Analysis]
10 Shu Y, Huang C, Liu H, Hu F, Wen H, Liu J, Wang X, Shan C, Li W. A hemicyanine-based fluorescent probe for simultaneous imaging of Carboxylesterases and Histone deacetylases in hepatocellular carcinoma. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 2022. [DOI: 10.1016/j.saa.2022.121529] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Alsayed RKME, Khan AQ, Ahmad F, Ansari AW, Alam MA, Buddenkotte J, Steinhoff M, Uddin S, Ahmad A. Epigenetic Regulation of CXCR4 Signaling in Cancer Pathogenesis and Progression. Semin Cancer Biol 2022:S1044-579X(22)00075-X. [PMID: 35346802 DOI: 10.1016/j.semcancer.2022.03.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]